Work

Abstract C038: Impact of assessment schedules on atezolizumab anti-drug antibody incidence rates

Year: 2026

Type: conference-abstract

Source: Cancer Immunology Research

DOI: 10.1158/2326-6074.io2026-c038

Authors: Richard S. Finn, Coen A. Bernaards, Steven J. Swanson, Barbara Gitlitz, Lily J. Nguyen, James Zanghi, Sophie Cousin

Institutions: University of California, Los Angeles, Genentech, Institut Bergonié

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7130434923

Cites:

Cited by:

Related to: